17th Mar 2026 14:00
Revenio Group Corporation | Stock Exchange Release | March 17, 2026 at 16:00:00 EET
Revenio Group Corporation has today transferred a total of 1,841 of its treasury shares (REGV1) to individuals included in Revenio’s share-based incentive plan RSP 2024â€"2026.
The transfer of shares is based on the decision announced by Revenio's Board of Directors in a stock exchange release on February 18, 2026, to grant the company’s own shares held by the company due to the fulfillment of the performance criteria of the RSP 2024â€"2026 share-based incentive plan.
After the transfer, Revenio Group Corporation holds a total of 75,850 of its treasury shares.
For further information, please contactRobin Pulkkinen, CFO, tel. +358 50 505 9932[email protected]
DistributionNasdaq Helsinki OyFinancial Supervisory Authority (FIN-FSA)Principal mediawww.reveniogroup.fi/en
Revenio Group in briefRevenio is a global provider of comprehensive eye care diagnostic solutions. The group offers fast, user-friendly, and reliable tools for diagnosing glaucoma, diabetic retinopathy, and macular degeneration (AMD). Revenio’s ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), fundus imaging devices, microperimeters, and perimeters as well as software solutions under the iCare brand.
In 2025, the Group’s net sales totaled EUR 109.7 million, with an operating profit of EUR 25.4 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.
Attachments
Change in the amount of Revenio Group Corporation’s treasury shares